Skip to main content

Currently Skimming:

Appendix E Recommendations Made in Recent Reports on the Medical Use of Marijuana
Pages 244-255

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 244...
... Bethesda, MD: National Institutes of Health. · World Health Organization.
From page 245...
... AMA House of Delegates Adequate and well-controlled studies of smoked marijuana should be conducted in patients who have serious conditions for which preclinical, anecdotal, or controlled evidence suggests possible efficacy, including AIDS wasting syndrome, severe acute or delayed emesis induced by chemotherapy, multiple sclerosis, spinal cord injury, dystonia, and neuropathic pain. British Medical Association Research on the clinical indications for medical prescription of cannabinoids should be undertaken.
From page 246...
... National Institutes of Health Evaluation of cannabinoids in the management of neuropathic pain, including HIV-associated neuropathy, should be undertaken. World Health Organization No recommendations made, although the report notes that some newly synthesized cannabinoids are extremely potent analgesics; how
From page 247...
... Further research is needed in other cases, such as postoperative nausea and vomiting. National Institutes of Health Inhaled marijuana merits testing in controlled, double-blind, randomized trials for nausea and vomiting.
From page 248...
... The ability of patients who smoke marijuana to titrate their dosage according to need and the lack of highly effective, inexpensive options to treat this debilitating disease create the conditions warranting formal clinical trials of smoked marijuana as an appetite stimulant in patients with AIDS wasting syndrome. British Medical Association Allowing the prescription of nabilone and THC for cancer chemotherapy and HIV/AIDS seems justified for preventing weight loss and treating anorexia in HIV/AIDS irrespective of whether the patient is experiencing nausea and/or vomiting.
From page 249...
... In the meantime, there is a case for the extension of the indications for nabilone and THC for use in chronic spastic disorders unresponsive to standard drugs. National Institutes of Health No recommendations are made, although the report notes that marijuana or the use of other cannabinoids as human therapies might be considered for treating spasticity and nocturnal spasms complicating multiple sclerosis and spinal cord injury.
From page 250...
... National Institutes of Health No recommendations made, although the report notes that marijuana or the use of other cannabinoids as human therapies might be considered for treating for some forms of dystonia. World Health Organization No recommendations made, although the report notes that cannabinoids have not yet been proven useful in the treatment of movement disorders.
From page 251...
... National Institutes of Health Further studies to define the mechanism of action and to determine the efficacy of /~9-tetrahydrocannabinol and marijuana in the treatment of glaucoma are justified. There does not appear to be any obvious reason to use smoked marijuana as a primary "stand-alone" investigational therapy, as there are many available agents for treatment, and these topical preparations seem to be potentially ideal.
From page 252...
... AMA House of Delegates British Medical Association Further research is needed to establish the suitability of cannabinoids for immunocompromised patients, such as those undergoing cancer chemotherapy or those with HIV/AIDS. National Institutes of Health Risks associated with smoked marijuana must be considered not only in terms of immediate adverse effects but also long-term effects in patients with chronic diseases.
From page 253...
... No recommendations made. AMA House of Delegates British Medical Association National Institutes of Health World Health Organization There is a need for controlled studies investigating the relationships between cannabis use, schizophrenia, and other serious mental disorders.
From page 254...
... British Medical Association Prescription formulations of cannabinoids or substances acting on the cannabinoid receptors should not include either cigarettes or herbal preparations with unknown concentrations of cannabinoids or other chemicals. National Institutes of Health Smoked marijuana should be held to standards equivalent to other
From page 255...
... AMA House of Delegates The National Institutes of Health should use its resources to support the development of a smoke-free inhaled delivery system for marijuana or THC to reduce the health hazards associated with the combustion and inhalation of marijuana. British Medical Association Pharmaceutical companies should undertake basic laboratory investigations and develop novel cannabinoid analogs that may lead to new clinical uses.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.